Cerulean Pharma Inc. and Adrian Senderowicz, senior vice president and chief medical officer, agreed that Senderowicz's employment with the company will end June 15.

In addition, the company and Scott Eliasof, senior vice president and chief scientific officer, agreed that Eliasof's employment with Cerulean will end June 30.

Senderowicz and Eliasof's decisions to terminate their employment did not involve any disagreements with the company, its management or the board.